结直肠癌中烷化剂突变特征的发现与特征
该研究利用三项美国前瞻性研究中的900例结直肠癌全外显子测序数据,结合饮食和生活方式信息,发现了一种结直肠癌中此前未描述的烷化剂突变特征,该特征在正常结肠隐窝中亦存在,与诊断前高摄入加工和未加工红肉相关,在远端结直肠更丰富,预测靶向KRAS p.G12D、KRAS p.G13D和PIK3CA p.E545K驱动突变,并与较差生存相关。
要点
- 发现结直肠癌中新的烷化剂突变特征,与红肉摄入相关。
- 该特征在远端结直肠更丰富,预测靶向KRAS p.G12D/p.G13D和PIK3CA p.E545K。
- 该特征与较差生存相关,提示红肉在结直肠癌发生发展中的作用。
核心结论
- 首次将结直肠癌突变特征与饮食成分(红肉摄入)联系起来,并提示红肉在结直肠癌发生和进展中的作用。
研究设计与样本
- 基于三项美国前瞻性研究中的900例结直肠癌病例,利用全外显子测序数据和广泛的饮食与生活方式信息进行分析。
主要发现
- 发现结直肠癌中此前未描述的烷化剂突变特征,并在正常结肠隐窝中存在类似突变过程。
- 该烷化剂特征与诊断前高摄入加工和未加工红肉相关。
- 该特征在远端结直肠更丰富,预测靶向KRAS p.G12D、KRAS p.G13D和PIK3CA p.E545K驱动突变,并与较差生存相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several risk factors have been established for colorectal cancer, yet their direct mutagenic effects in patients' tumors remain to be elucidated. Here, we leveraged whole-exome sequencing data from 900 colorectal cancer cases that had occurred in three U.S.-wide prospective studies with extensive dietary and lifestyle information. We found an alkylating signature that was previously undescribed in colorectal cancer and then showed the existence of a similar mutational process in normal colonic crypts. This alkylating signature is associated with high intakes of processed and unprocessed red meat prior to diagnosis. In addition, this signature was more abundant in the distal colorectum, predicted to target cancer driver mutations KRAS p.G12D, KRAS p.G13D, and PIK3CA p.E545K, and associated with poor survival. Together, these results link for the first time a colorectal mutational signature to a component of diet and further implicate the role of red meat in colorectal cancer initiation and progression. SIGNIFICANCE: Colorectal cancer has several lifestyle risk factors, but the underlying mutations for most have not been observed directly in tumors. Analysis of 900 colorectal cancers with whole-exome sequencing and epidemiologic annotations revealed an alkylating mutational signature that was associated with red meat consumption and distal tumor location, as well as predicted to target KRAS p.G12D/p.G13D.This article is highlighted in the In This Issue feature, p. 2355.
引用
- Gurjao C, Zhong R, Haruki K, et al. Discovery and Features of an Alkylating Signature in Colorectal Cancer. Cancer Discov. 2021. PMID: 34140290. doi:10.1158/2159-8290.CD-20-1656
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。